KRISTIN ECKEL-MAHAN to Protein Kinase Inhibitors
This is a "connection" page, showing publications KRISTIN ECKEL-MAHAN has written about Protein Kinase Inhibitors.
Connection Strength
0.660
-
Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. Cell Rep. 2025 Nov 25; 44(11):116313.
Score: 0.660
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.